Total Payments
$2,172
2024 Payments
$143.75
Companies
39
Transactions
148
Medicare Patients
5,984
Medicare Billing
$369,736
Payment Breakdown by Category
Food & Beverage$2,172 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,172 | 148 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $387.29 | 35 | $0 (2024) |
| Lilly USA, LLC | $225.11 | 16 | $0 (2024) |
| Novo Nordisk Inc | $206.73 | 13 | $0 (2021) |
| Abbott Laboratories | $190.53 | 7 | $0 (2022) |
| Shire North American Group Inc | $104.38 | 7 | $0 (2019) |
| PFIZER INC. | $102.87 | 8 | $0 (2019) |
| SANOFI PASTEUR INC. | $72.44 | 4 | $0 (2022) |
| Allergan, Inc. | $70.33 | 5 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $62.56 | 5 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $59.95 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $143.75 | 7 | Boston Scientific Corporation ($28.12) |
| 2023 | $64.44 | 3 | Edwards Lifesciences Corporation ($37.85) |
| 2022 | $393.28 | 32 | ABBVIE INC. ($160.69) |
| 2021 | $447.67 | 33 | AbbVie Inc. ($184.86) |
| 2020 | $139.66 | 9 | Abbott Laboratories ($42.69) |
| 2019 | $229.69 | 14 | Novo Nordisk Inc ($51.62) |
| 2018 | $518.12 | 33 | Shire North American Group Inc ($89.93) |
| 2017 | $235.19 | 17 | Lilly USA, LLC ($28.52) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/29/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 04/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Gastroenterology | ||||||
| 04/16/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: AMS 700_URO | ||||||
| 03/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/28/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Respiratory | ||||||
| 01/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/06/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $37.85 | General |
| 11/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2022 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: HEMATOLOGY | ||||||
| 09/28/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.93 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Diabetes | ||||||
| 07/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: PSYCHOLOGY | ||||||
| 07/18/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Diabetes | ||||||
| 06/29/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.43 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,653 | 3,468 | $298,401 | $111,189 |
| 2022 | 27 | 1,473 | 2,811 | $211,391 | $91,211 |
| 2021 | 28 | 1,365 | 2,793 | $209,297 | $83,864 |
| 2020 | 27 | 1,493 | 2,903 | $203,523 | $83,472 |
Total Patients
5,984
Total Services
11,975
Medicare Billing
$369,736
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 251 | 697 | $104,795 | $38,738 | 37.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 72 | 475 | $41,800 | $19,661 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 250 | $51,500 | $18,317 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 51 | 51 | $7,905 | $6,115 | 77.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 64 | 161 | $12,236 | $5,016 | 41.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 32 | 32 | $7,300 | $4,918 | 67.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 40 | $10,400 | $3,930 | 37.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 201 | 293 | $16,115 | $2,222 | 13.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 190 | 296 | $2,358 | $2,137 | 90.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 62 | 216 | $9,720 | $1,907 | 19.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 33 | $2,640 | $1,152 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,120 | $1,145 | 36.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $2,610 | $1,009 | 38.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 37 | 48 | $2,640 | $897.42 | 34.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 160 | 214 | $5,350 | $839.22 | 15.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 37 | 61 | $3,965 | $580.72 | 14.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 13 | $975.00 | $527.15 | 54.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 55 | 61 | $4,392 | $487.14 | 11.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 15 | $450.00 | $430.20 | 95.6% |
| 87276 | Detection test by immunofluorescent technique for influenza a virus | Office | 2023 | 20 | 21 | $525.00 | $330.75 | 63.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 17 | $1,105 | $275.40 | 24.9% |
| 87275 | Detection test by immunofluorescent technique for influenza b virus | Office | 2023 | 20 | 21 | $525.00 | $252.00 | 48.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 31 | 114 | $2,508 | $136.98 | 5.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 30 | 116 | $2,552 | $69.35 | 2.7% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 11 | 13 | $351.00 | $50.05 | 14.3% |
About Dr. Brian Coder, D.O
Dr. Brian Coder, D.O is a Family Medicine healthcare provider based in Broken Arrow, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427164888.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Coder, D.O has received a total of $2,172 in payments from pharmaceutical and medical device companies, with $143.75 received in 2024. These payments were reported across 148 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($2,172).
As a Medicare-enrolled provider, Coder has provided services to 5,984 Medicare beneficiaries, totaling 11,975 services with total Medicare billing of $369,736. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Broken Arrow, OK
- Active Since 08/21/2006
- Last Updated 10/03/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427164888
Products in Payments
- VRAYLAR (Drug) $201.03
- QULIPTA (Drug) $153.59
- Ozempic (Drug) $87.60
- JARDIANCE (Drug) $77.72
- TRULICITY (Drug) $70.03
- LYRICA (Drug) $67.76
- XARELTO (Drug) $62.56
- VYVANSE (Drug) $61.83
- XIFAXAN (Drug) $59.95
- UBRELVY (Drug) $59.25
- Neuromodulation Dspsbls and Accs (Device) $56.29
- Victoza (Drug) $49.70
- TRELEGY ELLIPTA (Drug) $44.81
- MYDAYIS (Drug) $42.55
- Aimovig (Biological) $41.25
- CONTRAVE (Drug) $40.51
- MOUNJARO (Drug) $37.86
- Tresiba (Drug) $37.27
- QELBREE (Drug) $35.72
- BioFire FilmArray (Device) $35.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Broken Arrow
Dr. James Campbell, D.o, D.O
Family Medicine — Payments: $43,510
Family Medicine $43,510
Dr. Ronald Oglesby, D.o, D.O
Family Medicine — Payments: $14,016
Family Medicine $14,016
Dr. Beau Jennings, Do, DO
Family Medicine — Payments: $12,231
Family Medicine $12,231
Dr. Christopher Chow, Md, MD
Family Medicine — Payments: $10,541
Family Medicine $10,541
Coy Peters, D.o, D.O
Family Medicine — Payments: $9,170
Family Medicine $9,170
Michael Sayler, D.o, D.O
Family Medicine — Payments: $9,088
Family Medicine $9,088